| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 31,324 | 33,345 | 48,748 | | Cost of Revenue | 2,705 | 3,138 | 3,188 | | | Gross Profit | 28,619 | 30,207 | 45,560 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 863 | 876 | 923 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 27,756 | 29,331 | 44,637 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (101,087) | (57,305) |
-
| | Earnings Before Interest And Taxes | 27,756 | 29,331 | 26,374 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 27,756 | 29,331 | 26,374 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (73,331) | (27,974) | 44,637 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (73,331) | (27,974) | 44,637 | | Preferred Stock And Other Adjustments | (4,574) | (5,823) | (5,203) | | | Net Income Applicable To Common Shares | ($77,905) | ($33,797) | $39,434 |
|
0.11% Nasdaq 0.00%
Income Statement
